Evidence map›Paper›PMID 24887235›Full record

ArticlePloS one2014

Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.

Ana Gracanin, Elpetra P M Timmermans-Sprang, Monique E van Wolferen, Nagesha A S Rao, Juraj Grizelj, Silvijo Vince, Eva Hellmen, Jan A Mol

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Ana GracaninDepartment of Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands.
Elpetra P M Timmermans-SprangDepartment of Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands.
Monique E van WolferenDepartment of Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands.
Nagesha A S RaoDepartment of Molecular Biology, Radboud University, Nijmegen, The Netherlands.
Juraj GrizeljClinic for Obestrics and Reproduction, Faculty of Veterinary Medicine, Zagreb, Croatia.
Silvijo VinceClinic for Obestrics and Reproduction, Faculty of Veterinary Medicine, Zagreb, Croatia.
Eva HellmenDepartment of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Jan A MolDepartment of Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands.
Utrecht University · NLCroatian Veterinary Institute · HRRadboud University Nijmegen · NLSwedish University of Agricultural Sciences · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pet dogs very frequently develop spontaneous mammary tumors and have been suggested as a good model organism for breast cancer research. In order to obtain an insight into underlying signaling mechanisms during canine mammary tumorigenesis, in this study we assessed the incidence and the mechanism of canonical Wnt activation in a panel of 12 canine mammary tumor cell lines. We show that a subset of canine mammary cell lines exhibit a moderate canonical Wnt activity that is dependent on Wnt ligands, similar to what has been described in human breast cancer cell lines. In addition, three of the tested canine mammary cell lines have a high canonical Wnt activity that is not responsive to inhibitors of Wnt ligand secretion. Tumor cell lines with highly active canonical Wnt signaling often carry mutations in key members of the Wnt signaling cascade. These cell lines, however, carry no mutations in the coding regions of intracellular Wnt pathway components (APC, β-catenin, GSK3β, CK1α and Axin1) and have a functional β-catenin destruction complex. Interestingly, however, the cell lines with high canonical Wnt activity specifically overexpress LEF1 mRNA and the knock-down of LEF1 significantly inhibits TCF-reporter activity. In addition, LEF1 is overexpressed in a subset of canine mammary carcinomas, implicating LEF1 in ligand-independent activation of canonical Wnt signaling in canine mammary tumors. We conclude that canonical Wnt activation may be a frequent event in canine mammary tumors both through Wnt ligand-dependent and novel ligand-independent mechanisms.

Indexed as

AnimalsBase SequenceBlotting, WesternCadherinsCell Line, TumorDNA PrimersDog DiseasesDogsHumansLigandsLymphoid Enhancer-Binding Factor 1Mammary Neoplasms, AnimalPolymerase Chain ReactionWnt ProteinsCadherinsDNA PrimersLigandsLymphoid Enhancer-Binding Factor 1Wnt Proteins

Identifiers

PMID24887235
PMCPMC4041801
OpenAlexW2092280338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.